
Reckless Rush to Reopen Threatens Chile’s Exemplary Vaccination Strategy
Easing restrictions without clear risk communication undercuts some of the country’s hard-won progress in fighting the pandemic

Easing restrictions without clear risk communication undercuts some of the country’s hard-won progress in fighting the pandemic

After a year away from friends and co-workers, people sometimes struggle to resume their public routines

Using home monitoring and other efficiencies instead of dragging people into hospitals could improve clinical trials after the pandemic

It took just four months to reach this global milestone, and hitting the two-billion mark could happen even faster, say scientists

Pandemic highlights for the week

Clear messaging and transparency are vital, say some experts on risk assessment and decision-making

Next-generation COVID-19 vaccines will not only tackle different versions of the virus but will provide solutions across the world at a fraction of the cost

It was good, on balance, for people’s mental health—but not so good for physical health

The agency’s latest guidelines are in line with a wealth of evidence that COVID is far less likely to be transmitted outside than indoors

Pandemic highlights for the week

Today we bring you the fifth episode in our podcast series: COVID, Quickly. Every two weeks, Scientific American ’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between...

Infectious disease physician-scientist Wilbur Chen discusses the rare cases of blood clots linked to the immunization

The virus is spreading faster than ever before in the country despite previous high infection rates in megacities, which should have conferred some protection

An anesthesiologist at the University of Michigan describes the new influx of patients and what this may mean for the pandemic’s trajectory

The risk of COVID transmission in schools is very low if precautions are taken

An infectious disease doctor answers questions about the CDC’s and FDA’s decision to pause the vaccine’s use over a possible link with blood clots

Researchers are searching for possible links between unusual clotting and the Oxford-AstraZeneca coronavirus vaccine

The reasons may include women’s roles as caregivers and their greater likelihood of seeking out preventive health care in general

Pandemic highlights for the week

Today we bring you the fourth episode in a new podcast series: COVID, Quickly. Every two weeks, Scientific American ’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between...
You have free articles left.

Support our award-winning coverage of advances in science & technology.
Already a subscriber? Sign in.